Archive for October, 2011

Ascorbate Oxidation Protocols: What should be added to the mix?

Friday, October 28th, 2011

About the time IVNTP started offering our 2-day Advanced Topics seminars (2009), research was coming out of the University of Kansas Medical Center, via Dr. Jeanne Drisko, director of the program of Integrative Medicine, indicating that ascorbic acid protocols in use at the time may not be the best for supporting cancer patients. When cancer patients are given high dose IV vitamin C (HDIVC), the objective is to cause oxidative effects at the tissue/tumor level by using the vitamin C to generate hydrogen peroxide.[i] IVNTP concurred with this research and incorporated the concept that future HDIVC protocols should contain only ascorbic acid and balancing amounts of specific minerals, e.g. calcium, magnesium and potassium. At this time we did not differentiate any advantages to specific mineral salts, such as calcium gluconate vs. calcium chloride.